Beatrice Schuler-Thurner

Title: Beatrice Schuler-Thurner: Innovator in Dendritic Cell Technology

Introduction

Beatrice Schuler-Thurner is a prominent inventor based in Spardorf, Germany. She has made significant contributions to the field of immunology, particularly in the development of dendritic cell technologies. With a total of 2 patents, her work focuses on enhancing vaccine production through innovative methods.

Latest Patents

Schuler-Thurner's latest patents revolve around the production of cryoconserved mature dendritic cells. The first patent describes a method for producing ready-to-use, antigen-loaded or unloaded, cryoconserved mature dendritic cells. This method is particularly aimed at creating vaccines that utilize these dendritic cells. Immature dendritic cells are cultivated with suitable maturation stimuli, and the resulting mature cells are then frozen. Importantly, these dendritic cells can be loaded with antigens prior to freezing. The second patent reiterates this innovative approach, emphasizing the potential for developing effective vaccines and compositions containing these frozen, mature dendritic cells.

Career Highlights

Beatrice Schuler-Thurner is associated with Argos Therapeutics, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in the field of vaccine technology, particularly in the context of dendritic cell applications.

Collaborations

One of her notable collaborators is Gerold Schuler, who has worked alongside her in various research initiatives. Their partnership has contributed to the advancement of dendritic cell technology and its applications in immunotherapy.

Conclusion

Beatrice Schuler-Thurner stands out as an innovative inventor in the realm of dendritic cell technology. Her patents and ongoing work at Argos Therapeutics, Inc. highlight her commitment to advancing vaccine development. Her contributions are paving the way for new therapeutic approaches in immunology.